foxo4-dri peptide senolytic human trial Frontiers FOXO4-DRI | FOXO4/p53 Interaction Blocker

Peptides that increase BDNF levels While BDNF mimetics work by directly activating TrkB receptors, a separate category of peptides achieves cognitive benefits by increasing the brain natural production of BDNF

J Cell Physiol 2011;226:29252933

Plant-based diets usually fall short unless fortified

It seems as though this significant change took place almost overnight

Phase 2 Side-Effect Frequencies at 4.5 mg/week (Lancet 2021) Side Effect Nausea Incidence at 4.5 mg/week 47% Side Effect Injection-site reactions Incidence at 4.5 mg/week 43% Side Effect Constipation Incidence at 4.5 mg/week 21% Side Effect Fatigue Incidence at 4.5 mg/week 20% Side Effect Allergic reactions (any) Incidence at 4.5 mg/week 10% Side Effect Vomiting Incidence at 4.5 mg/week 8% Side Effect Loose stools Incidence at 4.5 mg/week 7% Side Effect Headache Incidence at 4.5 mg/week 7% Side Effect Indigestion Incidence at 4.5 mg/week 4% Incidence was lower at lower doses

Many patients have both components, which is why the intake evaluation matters more than the compound choice